InterMune Canada has announced the availability of idiopathic pulmonary fibrosis (IPF) therapy, Esbriet, in Canada. University of Toronto professor and vice-chair of medicine and University Health Network IPF researcher and consultant ...
Tags: fibrosis therapy, InterMune, medicine
The European Commission has granted marketing authorization for Pharmaxis' Bronchitol as an add on therapy to cystic fibrosis (CF). The company developed Bronchitol to aid clear the airways of CF patients. Pharmaxis CEO Alan Robertson ...
Tags: cystic fibrosis, CF, Pharmaxis'Bronchitol